IMNM Institutional Ownership
Immunome Inc.
Latest close $25.52 as of Aug 5, 2026
IMNM institutional ownership at a glance
Follow Immunome Inc. institutional ownership through recent Schedule 13G and 13D filings. Compare reported shares, ownership percentages, filing dates, and changes in beneficial ownership over time.
Latest filing: T. Rowe Price Investment Management filed Schedule 13G amendment on May 15, 2026, reporting 16.4M shares and 14.50% beneficial ownership.
How to read Schedule 13 ownership changes
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
Institutional Research
This gauge summarizes recent agreement across tracked institutional activity.
1 accumulating across 1 comparable institution.
The overall consensus is public. Detailed holder comparisons, breadth history, ownership charts, and filing-specific signal analysis remain part of Investor and Pro research.
Price context
52-week position is market context and does not change the institutional consensus score.
Tracked institutions
Public holder names and filing freshness. Detailed institution-by-institution analysis is locked.
Beneficial ownership filing history
Showing 3 of 3 filing(s)| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| T. Rowe Price Investment Management CIK0001897612 | Mar 31, 2026 observed May 15, 2026 filed · 45d Schedule 13G amendment | Reported accumulation | 16.4M +5.7M | 14.50% +2.30 pts | $21.87 | $20.88 | $25.52 |
| T. Rowe Price Investment Management CIK0001897612 | Oct 31, 2025 observed Nov 7, 2025 filed · 7d Initial Schedule 13G | Initial Schedule 13G | 10.6M +4.9M | 12.20% +2.60 pts | $16.07 | $15.24 | $25.52 |
| T. Rowe Price Investment Management CIK0001897612 | Sep 30, 2024 observed Nov 14, 2024 filed · 45d Initial Schedule 13G | Initial Schedule 13G | 5.8M | 9.60% | $14.62 | $11.14 | $25.52 |
Related research
Compare IMNM with other securities showing similar institutional activity or recent accumulation across several tracked institutions.